Hims & Hers to Offer Eli Lilly Weight-Loss Drugs
Hims & Hers and Eli Lilly signed a deal for the telehealth platform to offer Lilly’s obesity drugs at self-pay prices.
By Kelly CloonanHims & Hers Health and Eli Lilly inked a deal for the telehealth platform to offer the pharmaceutical company's obesity drugs at self-pay prices, a move that comes amid fierce competition in the market for GLP-1 drugs.Under the agreement, patients who receive a prescription from a p…